… tomography to stage men with high-risk prostate cancer for nodal or distant metastases,
and reliably detect sites of disease in men with suspected metastatic prostate cancer. …

… Therefore, the upregulated levels of circulating miR-132 in CRPC patients with poorer
outcome in our study are unlikely to be derived from prostate cancer cells. Instead, miR-132 may …

… study was not designed to compare the 2 regimens, the levels of activity in this study appear
similar between the 2 … by PSA declines and objective tumor responses contrasts with results …

… phase 1–2 study was undertaken in five US centres in 140 patients. Patients with progressive,
metastatic, castration-resistant prostate cancer … data from phase 2 clinical trials of prostate, …

… same disease settings in the phase 3 AFFIRM and PREVAIL studies, and improved
progression-… in two randomised phase 2 studies. In the randomised PLATO study, patients …

… In summary, the current phase 2 trial has demonstrated that the addition of VEGF blockade
with bevacizumab to a docetaxel-based regimen for the treatment of patients with metastatic …

… In 2016, we activated a prospective phase 2 study of stereotactic MRgRT in patients with
localized PC and specifically investigated PROMs during the 1st year following treatment. The …

… -label, phase 2 randomized clinical trial, the 164 men with metastatic castration-resistant
prostate cancer treated … Overall, the observations of our phase 2 trial require further validation. …

… This study demonstrates a definite clinical response of androgen-independent prostate
cancer to APC immunotherapy. Currently we are studying this mode of therapy in Phase 3 trials. …

… pilot study with BAT, we sought to test BAT in patients with metastatic castration-resistant
prostate cancer who … To test these hypotheses, we did a phase 2 trial of BAT and subsequent …